This study was designed to identify possible electrical remodeling (ER) in transgenic (Tg) mice with over-expressed L-type Ca 2ϩ channels. Transient outward K ϩ current (I to ) and action potential duration (APD) were studied in 2-, 4-, 8-, and 9-to 12-month-old mice to determine linkage to ventricular remodeling (VR), ER, and heart failure (HF). BACKGROUND Prolongation of APD and reduction in current density of I to are thought to be hallmarks of VR and HF. Mechanisms are not understood.
It is well known that Ca 2ϩ homeostasis is vital in maintaining adequate regulation of the heart. When Ca 2ϩ handling becomes dysfunctional, as is the case when proteins that regulate intracellular calcium are over-expressed or "knocked out" in transgenic animals (Tg), pathophysiologic changes ensue. For example, Tg mouse lines with targeted over-expression of cardio-specific calsequestrin (1), calcineurin (2), Ca 2ϩ /calmodulin-dependent protein kinase-IV (3), Gs␣(4), and G␣q (5) develop cardiac hypertrophy and, eventually, heart failure (HF) as the animals age. The anatomic process of hypertrophy is generally referred to as "ventricular remodeling." The latter is frequently accompanied by arrhythmogenic changes known as "electrical remodeling." The latter typically is thought to include prolongation of action potential duration (APD), down-regulation of transient outward potassium current (I to ), and inward rectifier potassium current (I K1 ), decreased responsiveness to ␤-adrenergic stimulation, and alterations of intracellular Ca 2ϩ handling. Gwathmey et al. (6) were the first to show prolongation of the Ca 2ϩ signal and APD in trabeculae from failing human myocardium. Despite compelling evidence to implicate that I to is a key contributor in the repolarization process of the ventricular action potential (7), the role of I to in the APD remains unclear. The changes in I to that have been reported in hypertrophy and subsequent to myocardial infarction and HF are equivocal. Down-regulation of I to has been described in a number of rat models of myocardial hypertrophy (8) and in human HF (9) . In Tg mouse models of HF where G␣q (5) or calsequestrin is over-expressed (1), a marked downregulation of I to density appears to be associated with a prolongation of the APD. On the other hand, there are reports of an "up-regulation" of I to in hypertrophied cardiac myocytes (10 -12) and in cardiac myocytes after induced myocardial infarction (13) . Taken together, cellular hypertrophy is not always linked to a reduction in I to . The complexities of K ϩ -associated currents and the APD, as well as difficulties in trying to "link" I to and APD, have recently been nicely discussed by Roden (14) . On the other hand, most investigators, perhaps more intuitively than factually, feel that increases in intracellular Ca 2ϩ concentra-tion ([Ca 2ϩ ] i ) may lead to contractile dysfunction, hypertrophy, and HF (15) and that [Ca 2ϩ ] i increases may trigger downstream signaling cascades that initiate a "hypertrophic gene program" (16) . Enhanced Ca 2ϩ entry can extend the plateau phase of the action potential, thereby increasing the APD that, in turn, would at least theoretically result in elevated [Ca 2ϩ ] i , causing hypercontractility of an already compromised heart and arrhythmias at the onset of cardiac hypertrophy; Ca 2ϩ entering through the L-type voltagedependent calcium channel (L-VDCC) not only serves as a trigger for contraction but also may transduce the electrical signals into a series of biochemical signals in the heart. Backx et al. (17) supported this hypothesis in mice overexpressing an N-terminal fragment of Kv4.2, by showing that verapamil treatment prevented the progressively developed cardiomyopathy. The specific role of altered L-type Ca 2ϩ channels in the impaired Ca 2ϩ homeostasis of the failing heart (1, 5, 18, 19) is an area of considerable controversy.
We generated Tg mice, over-expressing the cardiac ␣ 1 subunit of the L-VDCC (20) in order to simulate a scenario in which there would be a sustained but low-level of an increased intracellular calcium. These animals exhibited a slowly developing hypertrophy and eventually died with a cardiomyopathic HF phenotype (21) . We hypothesize that a sustained increase of inward calcium current (I Ca ) (22, 23) , regardless of the source, is a major important mediator of hypertrophy associated with electrical remodeling. We studied these mice in order to reveal the underlying electrophysiologic basis of the electrical remodeling. Accordingly, the present study was designed to systematically characterize the electrophysiologic properties (I to and APD) of cardiac myocytes derived during aging in these Tg mice in order to determine if there is a consistent pattern of ion current changes in both ventricular and electrical remodeling. In this study, we report in vivo, in situ, and cellular evidence that Ca 2ϩ is the critical signal of cardiac hypertrophy and that the APD and I to are hallmarks of the electrical, but not the ventricular, remodeling processes.
METHODS

Isolation of ventricular myocytes and electrophysiology.
Cardiac ventricular myocytes isolation from 2-, 4-, 8-, and 9-to 12-month-old Tg and nontransgenic (Ntg) mice, whole cell voltage-and current-clamp recording methods, and data analysis were identical to those previously described by us (18, 20) . In the studies to determine recovery of I to from inactivation, a double pulse protocol was used. Two depolarizing pulses (from Ϫ80 mV to ϩ40 mV, 300-ms long) with a varying interpulse interval (from 20 ms to 3,000 ms) were applied every 10 s. The rapidly inactivating current is referred to as I to,fast , and the slowly inactivating current is termed I to,slow (10); I to is defined as the difference between the peak outward current (I to,peak ) and the I sus (the current remaining at the end of the 680 ms pulse for the same cells). All current amplitudes were normalized to the cell membrane capacitance (Cm) and expressed as densities (pA/pF). The experiments were carried out at room temperature (22 to 24°C). Western blot analysis. Membrane fractions were prepared from mouse hearts as previously described (21) . Protein samples were separated on SDS-PAGE, transferred to nitrocellulose membranes, and blocked in TBS-5% milk. Primary antibodies were incubated overnight at 4°C (anti-Kv1.4 ALOMONE, anti-Kv4.2, and Kv4.3; Chemicon Int.). Secondary antibodies were peroxidase-labeled anti-rabbit or antimouse IgG (Amersham). Antibody signals were detected by enhanced chemiluminescence and quantified by densitometry (Alpha Imager 2000, version 3.1; Alpha Innotech Corp.). All measurements were normalized to protein levels of mouse anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antibody (Chemicon Int.). Ex vivo hemodynamic measurements. The hearts were perfused in a retrograde manner at a constant coronary pressure (50 mm Hg) with oxygenated Krebs-Henseleit Buffer (37.4°C) in 9-to 12-month-old animals and in work-performing heart preparations in younger animals as previously described (23) . Echocardiography. In vivo ventricular function was measured with a noninvasive technique as previously described (24) . Noninvasive echocardiography was performed in ␣ 1 -over-expressed Tg and Ntg mice at ages of four and eight months. Noninvasive cardiac function was assessed by two-dimensional guided M-mode echocardiography. 
Statistical analysis.
Comparison between gene expression levels were made using unpaired Student t test or two-way analysis of variance (followed by Bonferroni's method for post-hoc pairwise multiple comparisons) for electrophysiology (EP) data to account for differences between individual animals and individual cells. Values are expressed as mean Ϯ SEM and considered significantly different at p Ͻ 0.05. Samples sizes (n) are listed as n ϭ x/y to denote x cells from y mice; only one measurement per cell was performed.
RESULTS
Electrophysiologic studies. APD. Action potentials recorded in Ntg and Tg ventricular myocytes electrically paced at 1 Hz (Fig. 1A , Table 1 ) were typically short (spiked) in Ntg cells, that is, no evidence of a "plateau" phase. The APD did not change significantly in Tg cells up to eight months of age. However, in older Tg animals (9 to 12 months), the average APD at 50% repolarization (APD 50 ) and APD 90 values were prolonged significantly compared with their age-matched Ntg counterparts. Despite the changes in APDs, the resting potential did not differ between the two groups. Transgenic cardiac myocytes (eight-month-old) demonstrated a higher sensitivity of the APD 90 after exposure to 4-aminopyridine (4-AP) (Figs. 1B and 1C) . We recorded very long APDs in 12 of 20 cardiac myocytes derived from six Tg mice after the application of 250 M 4-AP. The original recordings (Fig. 1C) illustrate that Tg myocytes after 4-AP developed early afterdepolarizations (EAD) and failed to repolarize. Figure 1C , shows five normal APs and five incidents of EADs. In this study, we could not record incidence of EADs from Ntg cardiomyocytes (n ϭ 16/5). Potassium currents. Subsequent experiments were designed to examine K ϩ currents. The I K1 is important in maintaining the resting membrane potential and in shaping the contour of the AP (Figs. 2A to 2D ). We found no significant differences between the groups in I K1 currentvoltage relationships up to nine months of age over a broad range of membrane potentials, particularly at the membrane potential range encountered during phase III repolarization of the AP, that is, from Ϫ40 mV to 80 mV. Despite the decrease in the density of I K1 after nine months in the Tg mice, the resting membrane potential was not significantly altered (Tables 1 and 2) .
Cell membrane capacitance (Cm) of ventricular myocytes was indistinguishable in two-month-old cardiac myocytes.
Massive cardiac enlargement occurred at the 9-to 12-month time period with a significant increase in Cm of Tg myocytes (184.3 Ϯ 9.2 pF, Ntg, n ϭ 28/6 vs. 262.7 Ϯ 9.2 pF, Tg, n ϭ 45/6, p Ͻ 0.05) ( Table 2) , which contained large pleomorphic nuclei not observed in the Ntg myocytes.
We then investigated whether changes in the APD were associated with alterations in I to , as has been suggested (7). The current-voltage relationships for I to,peak and I to are illustrated in Figures 3A and 3B . In both Ntg and Tg cells, the threshold for the activation of I to was about Ϫ20 mV. The I to in the Tg cells was significantly higher in all age groups except in the 9-to 12-month-old Tg compared with the Ntg cells ( Table 2 ). Similar to I to,peak density, the I sus , was also significantly higher than Ntg in the two-, four-, and eight-month Tg myocytes at membrane voltages of 30 to 80 mV. The I sus density remained the same as in the Ntg myocytes in the 9-to 12-month-old mice. It is conceivable that with progression to hypertrophy and HF, a decrease in the density of the I sus occurs (Figs. 3D to 3F, Table 2 ). Steady-state inactivation curves were obtained in the Ntg and Tg myocytes to compare the availability of I to channels for activation and to determine whether the observed changes in current density are associated with altered channel kinetics. Under these conditions, the residual steady-state current was approximately 50% of the peak current level (Fig. 4A) . The mean values of V 0.5 and k for the Ntg and the Tg cells were evaluated in presence of 0.3 mM CdCl 2 . No significant difference was observed in V 0.5 between the Ntg and Tg cells at 4-and 9-to 12-month age groups ( Table 2) . We previously considered whether changes in the availability of Ca 2ϩ channels could account for the increased I Ca (21, 22) ; therefore, in addition, we analyzed the steady-state inactivation characteristics of I Ca shown in Figure 4B and Table 2 .
We next compared the time course of the decay phase of I to , which has been shown to be largely independent of voltage, in the 4-and 9-to 12-month-old Ntg and Tg cardiac myocytes. At ϩ40 mV test potentials, there were significant differences in time course of fast inactivation ( fast ) between the Ntg and Tg cells in the four-month-old age group (Ntg, 30.9 Ϯ 1.2 ms, n ϭ 27/4 vs. Tg, 36.2 Ϯ 0.7 ms, n ϭ 37/4, p Ͻ 0.05). The slow was not significantly different between Ntg and Tg mice at this age. In contrast, slow was significantly increased in myocytes from 9-to 12-month-old Tg mice at ϩ40 mV (Ntg, 580. 
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Electrical Remodeling in a Failing-Heart Model 4D). The slowed inactivation kinetics of I to suggested differences in recovery from inactivation, prompting the study of restitution of I to . The recovery from inactivation of I to in Ntg and Tg mouse cardiac myocytes was displayed in Figures 4E and 4F , respectively. The slow at Ϫ80 mV is 237.9 Ϯ 16.2 ms, n ϭ 14/3, in the Ntg was significantly shorter than that in the Tg group, 491.2 Ϯ 34.8 ms, n ϭ 36/4, p Ͻ 0.001 (Table 2) . Western blot analysis was performed to see whether the changes in I to density could be correlated with quantitative changes in the K ϩ channel protein expression. Interestingly, the Kv1.4 protein was up-regulated in the eight-month-old mice (Figs. 5A and 5B). The increase in Kv1.4 coincided with the increase of the slow of recovery from inactivation. In spite of this up-regulation, Kv4.3 protein levels were not altered in the two-, four-, and eight-month-old Tg mice (Fig. 5A, middle panel) . Densitometric analysis of Kv4.2 from 9-to 12-month-old Tg mice revealed a decrease 41.4 Ϯ 6.9% (n ϭ 3, p Ͻ 0.05) compared with Ntg. This observation is consistent with the EP data on I to (Fig. 3) indicating a 34% decrease. Hemodynamic study. The induced hypertrophy in the Tg mice is compensated in the first six to eight months (Table  3) of life but then progresses into frank HF. Our hemodynamic measurements in Tg animals bear this out. In fact, hearts taken from the 9-to 12-month-old Tg animals could not sustain a working mode, and, even in the Langendorff mode, these hearts revealed a very low basal contractility and deteriorated rapidly. Echocardiography. At four months, Tg mice showed a mild reduction in percentage fractional shortening (%FS) and heart rate, but other parameters did not change significantly (Table 3 ). In contrast, at eight months and older, severe cardiac enlargement and marked cardiac dysfunction were evident. This late phenotype was associated with a progressive increase in the left ventricular mass, decrease in %FS, and increase in left ventricular end-diastolic dimension and left ventricular end-systolic dimension (Fig. 6) .
DISCUSSION
In the present study, age-associated hypertrophy (ventricular remodeling) in Tg mice exhibited changes in I Ca (21, 22) , I to density, and APDs. Barry et al. (25) and Wickenden et al. (26) demonstrated the importance of I to in controlling the waveform of the mouse ventricular AP. These investigators generated Tg mice using a dominant negative approach by over-expressing a pore mutant (Kv4.2W362F) (lack of I to,fast ), (25) and Kv4.2N-HA, of Kv4.2 (decreased I to ) (26) , respectively. The APs in isolated ventricular myocytes from these Tg mice were substantially broader than from those of Ntg. However, hypertrophy was not reported in the Kv4.2W362F Tg mice, despite the fact that the functional knock-out of I to increased the APD and attenuated the density of I to . On the contrary, the Kv4.2N-HA Tg mice developed signs of hypertrophy, albeit at older ages (Ͼ4 months old).
Xu et al. (27) , in the dominant-negative Kv2 ␣ subunit mice, showed that I K,slow (slow component of the delayed rectifier current) was selectively reduced and was associated with a marked AP prolongation in ventricular myocytes; however, no signs of hypertrophy were observed. It is apparent that removal of Kv4-and Kv2-mediated currents (I to ) do not pari passu result in cardiac hypertrophy.
In contrast to a number of models of cardiac hypertrophy previously documented in which there is a down-regulation of I to and I K1 , we observed a modest, though surprising, increase in I to,peak , I sus , and I to up to eight months of age in our Tg model of cardiac hypertrophy. Furthermore, our data regarding I sus agree with previous results obtained from calsequestrin over-expressed Tg mice (1) . A variety of factors have been suggested to account for this phenome- 
*p Ͻ 0.05; †p Ͻ 0.001. I K1 ϭ inward rectifier potassium current; I to ϭ transient outward potassium current; Ntg ϭ nontransgenic; Rec. Inact. ϭ recovery from inactivation; Tg ϭ transgenic; I sus ϭ the current remaining at the end of the 680 ms pulse; fast ϭ fast time constant of I to inactivation or I to recovery from inactivation; slow ϭ slow time constant of I to inactivation or I to recovery from inactivation.
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Electrical Remodeling in a Failing-Heart Model non, but the mechanisms are still unclear (28) . We offer the speculation that the slight I to up-regulation may provide a protecting "balance mechanism" to obtund excessive lengthening of the APD and Ca 2ϩ flux, in order to minimize the incidence or onset of fatal ventricular arrhythmias.
Our data on I to and I Ca (21) provide important but opposing roles in the prolongation of the APD. The changes in I to,peak and I sus (up to eight months of age) should contribute to a shortening of APD and, indeed, we observed perhaps a slight decrease or no change in APD in the two-, four-, and eight-month-old Tg cardiac myocytes. One must consider that the altered expression of Ca 2ϩ -handling proteins plays a significant role in prolongation of APD, and the relationship between APD and I to,fast is multifactorial and complicated, at least according to model studies (29) . Prolonged APD in human ventricular myocytes from patients with HF (30) may theoretically cause a slowed diastolic decline of [Ca 2ϩ ] i and a reduced Ca 2ϩ sequestration by the sarcoplasmic reticulum, thereby elevating diastolic Ca 2ϩ . In our experiments, the APD was slightly decreased in cardiac myocytes, recorded from fourmonth-old Tg mice. One possibility to account for this change is that an acceleration of [Ca 2ϩ ] i reuptake occurs, which should increase the sarcoplasmic reticulum calcium load and, thus, augment systolic myocardial function (20, 23) . Indeed, this hypothesis was supported by Song et al. (22) who found an enhanced rate of Ca 2ϩ transient decay in our four-month-old Tg mice. A logical explanation for the APD prolongation at the end stage of HF could be enhanced I Ca (21, 22) , Na ϩ -Ca 2ϩ exchanger (NCX) (22) and down-regulation of I to . Moreover, the protein expression level of Kv4.2 (underlying the cardiac I to,fast ) decreased at the advanced ages. The NCX also plays an important role in Ca 2ϩ homeostasis in mouse heart (31) , and an increase in its forward mode of exchange might be expected to decrease contractility. We observed, however, an increased basal contractility in the four-month-old Tg mice, and the NCX activity was up-regulated (22) . Less information is available concerning the reverse mode of exchange via the NCX, but we cannot rule out the role in "Ca 2ϩ overload," which is thought to lead to arrhythmias.
In the fetal mouse ventricle, the contribution of the predominant Kv1.4 subunit to I to,slow has been confirmed in Kv1.4 knockout mice (32) , and in animals generated by crossbreeding the Kv4.2 (W362F) and the Kv1.4
Ϫ/Ϫ mice (33). The fetal Kv1.4 subunit disappears in the adult, but we have now documented its "reappearance" during the hypertrophy process. Guo et al. (33) and Wickenden et al. (34) suggest that the up-regulation of Kv1.4 ␣ subunit (and I to,slow ) is a "protective mechanism" against arrhythmogenesis. We feel that such a process occurs in the present mouse model. We found a correlation between slow recovery kinetics of I to and an elevation in Kv1.4 protein levels in the Tg model. We did not observe differences in the steadystate inactivation of I to between Tg and Ntg; therefore, the slight up-regulation in I to density in the Tg myocytes appears to be due to an increased number of functional K ϩ channels.
Our results also revealed an occurrence of EADs in phase 2 of the AP from eight-month-old Tg myocytes after application of the non-specific K ϩ channel blocker 4-AP. This is quite important. It has been suggested that L-type I Ca and NCX current are candidate inward currents for initiating arrhythmia-triggering EAD in electrically remodeled myocardium (35) ; however, the precise molecular mechanism, responsible for the EAD generation, has not been defined and/or is controversial (36, 37) . Study limitations. Gender differences and regional differences in current densities of myocytes are well known, but, at this time, we did not take these parameters into consideration. Conclusions. Taken together, our electrophysiologic findings show that the sustained, increased ingress of Ca 2ϩ (21, 22) initiates a hypertrophy gene program in a very slow, but progressive manner leading eventually from hypertrophy to HF. We suggest that the progression of the disease is accompanied by electrophysiologic remodeling. To recapitulate, we observed an up-regulation of the I to with no change in APD during the development of compensatory 
